Cornell researchers are exploring a new approach to reducing the spread of mosquito-borne viruses through seminal fluid proteins from male mosquitoes that disrupt the reproductive biology in females.
From studying labor law to understanding obesity, about undergraduate scholars shared their results at the Hunter R. Rawlings III Research Scholars Senior Expo and at CURBx, April 19.
Cornellians gathered March 4 for talks on food ethics by Andrew Chignell, visiting associate professor of philosophy, and on small farms by Anu Rangarajan, director of the Cornell Small Farms Program.
Ultrasmall Cornell dots armed with antibodies are another weapon in the fight against cancer, says Uli Wiesner, professor of materials science and engineering.
A naturally produced chemical exacerbates infection by a common bacteria, rendering the infection significantly harder for the body to clear, according to new Cornell cross-campus research.
A new study shows the cost of forgoing antibiotics on dairy farms would average out to $61 per cow annually and is studying the impact such a decision would have.
The first-ever 'disease in a Petri dish' platform that models human colon cancer derived from stem cells has been developed by Weill Cornell Medicine investigators, allowing them to identify a targeted drug treatment for a common, inherited form of the disease.
A newly discovered type of genetic mutation in cancer cells may provide clues about the disease's origins and offer new therapeutic targets, according to research from Weill Cornell Medicine and the New York Genome Center.
Weill Cornell Medicine has entered into an agreement with Tahoe Investment Group to assist in the development of an international hospital in Shanghai, China.
Dr. Lewis C. Cantley, the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, has been awarded the 2016 Wolf Prize in Medicine for his research discoveries.